Insulet Corp (PODD) stock

PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value

$150.03+1.97 (+1.33%)

Close on Nov 11, 2026Market cap $10.41BP/E 24.4Yield –

Insulet EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Insulet's EV/EBITDA was 17.8× on Nov 11, 2026, against 45.6× a year earlier. Over the last 5 years it ranged from 15.6× to 227.0×, with a median of 50.9×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	17.8×	−21.9
2025	Dec 31, 2025	39.7×	−9.2
2024	Dec 31, 2024	49.0×	−27.7
2023	Dec 29, 2023	76.6×	−91.3
2022	Dec 30, 2022	167.9×	+31.3
2021	Dec 31, 2021	136.7×	−9.1
2020	Dec 31, 2020	145.8×	−8.0
2019	Dec 31, 2019	153.7×	−51.6
2018	Dec 31, 2018	205.4×	−380.2
2017	Jul 31, 2017	585.6×	+79.9
2015	Apr 30, 2015	505.6×	–